UAMY Rallies 11.6%, But Valuation Signals Caution

Forward-Looking Analysis

Based on the provided news summaries, specific quantitative earnings expectations for United States Antimony (UAMY) for the 2026Q2 period, including projected revenue, net income, EPS estimates, and key analyst price targets, are not available. The provided text contains no consensus forecasts, analyst upgrades, or downgrades for UAMY. The "Earnings Calendar" section describes general functionality for tracking EPS and revenue surprises but does not list UAMY's specific forecast data. Consequently, no forward-looking financial metrics can be extracted or synthesized from the source material. The only forward-looking mention is a general TipRanks headline noting the setting of a date for Q2 results, without providing numerical guidance. Therefore, an analysis of projected revenue, net profit, or EPS estimates cannot be generated as the required data points are absent from the provided content.

Historical Performance Review

In the 2026Q1 period, United States Antimony reported a revenue of $6.78 million, accompanied by a gross profit of $1.11 million. However, the company faced significant profitability challenges, posting a net income loss of $11.29 million. This negative performance was reflected in an Earnings Per Share (EPS) of -$0.08. The substantial gap between gross profit and net income indicates high operating expenses or other non-operating costs that eroded the top-line gains, resulting in a notable quarterly loss for shareholders during this period.

Additional News

Recent market activity for United States Antimony (UAMY) highlights a sharp stock performance alongside valuation reassessments. The stock experienced a significant 11.6% rally in a single session, drawing fresh investor attention and prompting a reevaluation of recent returns. Over a three-year period, UAMY has delivered a substantial total return, yet recent valuation analysis suggests shares are currently trading near intrinsic fair value following this extended run. As of early August 2026, the stock price was reported at $6.94, with a market capitalization of $1.11 billion. Trading volume has been elevated, with recent sessions showing volumes around 6.18 million shares against an average of 5.08 million. The stock has traded within a 52-week range of $3.41 to $19.71. Analyst commentary notes that despite the large historical returns, current valuation metrics indicate the stock is no longer considered a deep bargain, sitting close to its estimated fair value.

Summary & Outlook

United States Antimony exhibits mixed financial health, characterized by strong top-line momentum but persistent bottom-line losses, as evidenced by the $11.29 million net loss in Q1 2026. The primary growth catalyst is the recent sharp stock rally and substantial three-year return, driven by market interest in critical minerals like antimony. However, the risk lies in the current valuation, which analysts suggest is near intrinsic fair value, potentially limiting immediate upside. Given the negative EPS and P/E ratio of -57.47, coupled with the stock trading at the higher end of its recent range relative to fair value, the outlook is cautiously neutral. Investors should monitor whether operational improvements can turn net income positive to justify current valuations, as the current price reflects significant prior gains without clear near-term profit acceleration.